ATE88631T1 - Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen. - Google Patents

Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.

Info

Publication number
ATE88631T1
ATE88631T1 AT87907043T AT87907043T ATE88631T1 AT E88631 T1 ATE88631 T1 AT E88631T1 AT 87907043 T AT87907043 T AT 87907043T AT 87907043 T AT87907043 T AT 87907043T AT E88631 T1 ATE88631 T1 AT E88631T1
Authority
AT
Austria
Prior art keywords
cardiovascular
risk
under treatment
persons
therapy
Prior art date
Application number
AT87907043T
Other languages
English (en)
Inventor
Richard Cotter
Robert C Johnson
Michael Ward
David C Madsen
Anthony J Valicenti
Michael P Menard
Hugh N Tucker
Original Assignee
Clintec Nutrition Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25425820&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE88631(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Clintec Nutrition Co filed Critical Clintec Nutrition Co
Application granted granted Critical
Publication of ATE88631T1 publication Critical patent/ATE88631T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT87907043T 1986-09-17 1987-09-16 Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen. ATE88631T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90844786A 1986-09-17 1986-09-17
EP87907043A EP0283513B1 (de) 1986-09-17 1987-09-16 Zusatznahrung bzw. therapie für personen mit risiko oder in behandlung für arteriosklerotische vaskuläre, kardiovaskuläre und/oder thrombotische erkrankungen
PCT/US1987/002347 WO1988001861A1 (en) 1986-09-17 1987-09-16 Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases

Publications (1)

Publication Number Publication Date
ATE88631T1 true ATE88631T1 (de) 1993-05-15

Family

ID=25425820

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87907043T ATE88631T1 (de) 1986-09-17 1987-09-16 Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.

Country Status (5)

Country Link
EP (1) EP0283513B1 (de)
AT (1) ATE88631T1 (de)
AU (1) AU596880B2 (de)
DE (1) DE3785667T2 (de)
WO (1) WO1988001861A1 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
DE69005298T2 (de) * 1989-03-30 1994-04-21 Kabi Pharmacia Ab Arznei-lipid-zusammensetzung für parenterale nahrung.
JPH07102112B2 (ja) * 1990-04-06 1995-11-08 大塚製薬株式会社 高蛋白高粘性栄養補給食品組成物
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
US5922345A (en) * 1990-12-07 1999-07-13 Scotia Holdings Plc Nutrition
ES2157898T3 (es) * 1991-01-24 2001-09-01 Martek Corp Aceites microbianos y usos de los mismos.
SE9200541D0 (sv) * 1992-02-24 1992-02-24 Kabi Pharmacia Ab New usee of omega-3-fatty acids
AU3374593A (en) * 1992-04-10 1994-04-14 Clintec Nutrition Company Improved high protein liquid nutrition for patients with elevated wound healing requirements
US5373595A (en) * 1993-03-12 1994-12-20 Irvin Industries Canada Ltd. Air support device
NZ248605A (en) * 1993-05-28 1994-12-22 Abbott Lab Enteral nutritional product comprising protein and fat
NZ248603A (en) * 1993-05-28 1994-12-22 Abbott Lab Nutritional product for enteral nutritional support of hiv victims comprising proteins and fat
CN1110112A (zh) * 1994-04-11 1995-10-18 贾增申 一种氨基酸固体饮料及其制备方法
SE9402027D0 (sv) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
EP0689835A3 (de) * 1994-06-30 1996-04-17 Ajinomoto Kk Zusammensetzung enthaltend ein Aminosäurengemisch und mindestens ein N-3 Fettsäure
US5589468A (en) * 1995-01-13 1996-12-31 Clintec Nutrition Co. Method for providing nutrition to elderly patients
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
AU6279398A (en) * 1997-02-21 1998-09-09 Beth Israel Deaconess Medical Center A novel nutritional therapy which minimizes plasma cholecystokinin (cck) levels
IT1291127B1 (it) 1997-04-01 1998-12-29 Sigma Tau Ind Farmaceuti Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica
JP3937423B2 (ja) * 1999-01-19 2007-06-27 ニプロ株式会社 アミノ酸含有アルブミン製剤
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
KR100843703B1 (ko) 2000-07-21 2008-07-04 이섬 리서치 디벨러프먼트 컴파니 오브 더 히브루 유니버시티 오브 예루살렘 양극성 장애에서의 조증을 치료하기 위한 벨프로익산 및 2-벨프로에닉산 아미드 유도체의 용도
DE102005058369A1 (de) * 2005-12-06 2007-06-14 Lts Lohmann Therapie-Systeme Ag Ungesättigte Fettsäuren als Thrombin-Inhibitoren
CN101703248B (zh) * 2009-10-23 2013-04-03 中国科学院南海海洋研究所 一种含海洋生物活性多糖的肠内营养制剂及其制备方法和用途
US20150283163A1 (en) * 2014-04-04 2015-10-08 Organic Medical Ventures, L.L.C. Muscle treatment composition and method making same
KR102195090B1 (ko) * 2019-01-31 2020-12-24 에이치케이이노엔 주식회사 오메가 지방산을 포함하는 약학 조성물 및 이를 포함하는 수액제제

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
US4438144A (en) * 1980-07-31 1984-03-20 Blackburn George L Amino acid preparation and therapy for treatment of stress and injury
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
US4687782A (en) * 1984-12-10 1987-08-18 Nutri-Fuels Systems, Inc. Nutritional composition for enhancing skeletal muscle adaptation to exercise training
IL77629A (en) * 1985-01-22 1989-07-31 Abbott Lab High fat,low carbohydrate enteral nutritional for mula
ATE65406T1 (de) * 1985-01-29 1991-08-15 Abbott Lab Enterales hypoallergenisches ernaehrungsrezept.
SE8601828D0 (sv) * 1986-04-21 1986-04-21 Novo Industri As Enteral diet product and agent for production thereof
DE3783206T2 (de) * 1986-10-27 1993-05-27 Abbott Lab Fluessige naehrwert-tabelle fuer glukose-intoleranz.

Also Published As

Publication number Publication date
EP0283513B1 (de) 1993-04-28
DE3785667T2 (de) 1994-07-21
AU8152087A (en) 1988-04-07
AU596880B2 (en) 1990-05-17
EP0283513A4 (de) 1989-12-28
EP0283513A1 (de) 1988-09-28
WO1988001861A1 (en) 1988-03-24
DE3785667D1 (de) 1993-06-03

Similar Documents

Publication Publication Date Title
DE3785667D1 (de) Zusatznahrung bzw. therapie fuer personen mit risiko oder in behandlung fuer arteriosklerotische vaskulaere, kardiovaskulaere und/oder thrombotische erkrankungen.
IT8423086A1 (it) Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
DE69327159D1 (de) Nahrung für mit HIV infizierte Menschen
NZ299464A (en) Use of gamma linolenic or dihomogamma linolenic acid in the treatment of Huntington's Chorea
DK0764405T3 (da) Ernæringspræparat
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
AU628662B2 (en) Dietary supplement and method of minimizing effects of infection through diet
EP0615753A1 (de) Formulierung zur Verwendung durch Raucher
SE8405308L (sv) Farmaceutisk komposition och forfarande for framstellning av densamma
WO2002015719A3 (en) Nutritional composition
DE69525150D1 (de) Nahrungsprodukt zur behandlung der ulzerativen kolitis sowie verwendung desselben
ATE186645T1 (de) Nahrungsmittel für menschen während strahlen- und/oder chemotherapie
NO990934L (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
DE69005062D1 (de) Fettsäuren zur Behandlung und Prävention von Hautschäden durch Radiotherapie.
AU1489688A (en) Omega-3 fatty acids in traumatic injury treatment
DE3750426D1 (de) Mittel zur Verbesserung spezifischer Eigenschaften des Blutes.
ES2082390T3 (es) Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias.
DE3574446D1 (de) Nahrungsmittel, getraenke, genussmittel oder pharmazeutisches zum oralen verabreichen bestimmtes praeparat, das saccharose enthaelt.
AU5148496A (en) Process for producing foods for premature babies and infants and dietetic foods
Guembel Change of arachidonic acid and docosa-hexaen acid speculum in the serum of people having heart trouble on a coronary diet with mackerel.).
McGarry et al. Utilization of Diet on the Development of Coronary Artery Disease
Snedcal CONGRESS OF NIUTRiTION

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
EEWE Authorization for restitution
UEP Publication of translation of european patent specification
RZN Patent revoked